Stockholders' Equity (Tables)

2 Months Ended

9 Months Ended

12 Months Ended

Mar. 31, 2014

Dec. 31, 2014

Jan. 31, 2014

Stockholders' Equity Note [Abstract]

Schedule of Nonvested Share Activity

A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows for the two months ended March 31, 2014:

			Weighted Average Remaining Vesting		Weighted Average Per Share		Weighted- average Per Share
			Life		Intrinsic		Grant Date
	Shares		(In years)		Value		Fair Value
Unvested or unlapsed shares - January 31, 2014		101,296		1.5	$	-	$	4.10
Granted		-		-		-		-
Vested / lapsed		(10,555)		-		-		-
Forfeited		-		-		-		-
Unvested or unlapsed shares - March 31, 2014		90,741		1.3	$	-	$	4.10

A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows for the nine months ended December 31, 2014:

		Weighted Average Remaining Vesting	Weighted Average Per Share		Weighted- average Per Share
		Life	Intrinsic		Grant Date
	Shares	(In years)	Value		Fair Value
Unvested or unlapsed shares, beginning of period	90,741	1.3	$	-	$	4.10
Granted	-	-		-		-
Vested / lapsed	(71,667)	-		-		-
Forfeited	-	-		-		-
Unvested or unlapsed shares, end of period	19,074	1.1	$	0. 90	$	4.10

A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows for the year ended January 31:

		Weighted-average
		Grant Date
	Shares	Fair Value
Unvested or unlapsed shares - February 1, 2012	-	$	-
Granted	575,000		3.00
Vested / lapsed	(391,482)		3.00
Forfeited	-		-
Unvested or unlapsed shares - January 31, 2013	183,518	$	3.00
Granted	-		-
Vested / lapsed	(82,222)		2.10
Forfeited	-		-
Unvested or unlapsed shares - January 31, 2014	101,296	$	4.10

Fair Value Of Closing Stock Price Based On Assumptions [Table Text Block]

The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:

Expected term (in years)	3.0
Volatility	17.4	%
Dividends	0.0	%
Interest rate	0.82	%

The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:

Exercise Price	$	4.10
Expected Term (in years)		4.59
Volatility		26.0	%
Dividend rate		0.0	%
Interest rate		0.5	%

The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:

Expected term (in years)	3.0
Volatility	29.7	%
Dividends	0.0	%
Interest rate	0.5	%

The fair value of the 40,000 stock options of $ 69,464 was determined under the Black-Scholes option pricing model using the Company’s closing stock price on the date of grant and the following weighted-average inputs:

Exercise Price	$	5.00
Expected Term (in years)		3.0
Volatility		29.7	%
Dividend rate		0.0	%
Interest rate		0.64	%

Fair Value Of Options Granted Based On Assumptions [Table Text Block]

The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:

Exercise Price	$	0.04
Expected Term (in years)		3.00
Volatility		29.7	%
Dividend rate		0.0	%
Interest rate		0.6	%

The calculation was based on the estimated fair value of the Company’s stock price on the date of grant and the following weighted-average inputs:

Exercise Price	$	4.70
Expected Term (in years)		6.00
Volatility		67.2	%
Dividend rate		0.0	%
Interest rate		1.4	%

Stock Option Transactions Under Stock Option Plans

Stock option activity for the two months ended March 31, 2014 is summarized below:

	Shares		Weighted  Average  Per Share  Exercise  Price		Weighted  Average Remaining Life (Years)		Weighted Average Per Share Intrinsic Value
Balance, January 31, 2014		735,800	$	1.70		9.0	$	1.60
Granted		-
Cancelled		(88,767)		2.30		7.9		-
Exercised		-						-
Expired		-						-
Forfeited		(18,333)		2.10		8.5		-
Balance, March 31, 2014		628,700	$	2.00		8.7	$	1.10
Vested and exercisable - March 31, 2014		526,089	$	1.90		7.3	$	1.20

Stock option activity for the nine months ended December 31, 2014 is summarized below:

	Shares	Weighted Average Per Share Exercise Price		Weighted Average Remaining Life (Years)	Weighted Average Per Share Intrinsic Value
Balance, beginning of period	628,700	$	2.00	8.7	$	1.10
Granted	85,500		10.00	-		-
Cancelled	(10,000)		-	-		-
Exercised	-		-	-		-
Expired	-		-	-		-
Forfeited	-		-	-		-
Balance, end of period	704,200	$	2.60	8.2	$	1.50
Vested and exercisable, end of period	623,256	$	2.20	7.3	$	1.80

Stock option activity for the years ended January 31, 2014 and 2013 is summarized below:

01	Shares		Weighted Average Per Share Exercise Price		Weighted Average Remaining Life (Years)		Aggregate Intrinsic Value
Balance, February 1, 2012		115,000	$	1.50		8.9	$	-
Granted		422,500		1.90		9.2		-
Exercised		(7,500)		2.10		-		-
Expired		-		-		-		-
Forfeited		-		-		-		-
Balance, January 31, 2013		530,000		1.79		9.1	$	-
Granted		308,500		1.80		9.4		-
Cancelled		(102,025)		2.22		8.6		-
Exercised		-		-		-		-
Expired		-		-		-		-
Forfeited		(675)		7.90		9.0		-
Balance, January 31, 2014		735,800	$	1.71		9.0	$	-
Vested and exercisable - January 31, 2014		606,689	$	1.60		9.1	$	-

Summary of Restricted Stock Award

The following table summarizes the restricted stock award in the ACO Plan during the two months ended March 31, 2014:

	Shares		Weighted Average  Remaining  Vesting Life (Years)		Weighted Average Per Share Intrinsic Value		Weighted  Average Per Share Fair Value
Balance, January 31, 2014		3,752,000		1.0	$	0.02	$	0.03
Granted		-		-		-		-
Released		-		-		-		-
Balance, March 31, 2014		3,752,000		0.8	$	0.02	$	0.03
Vested and exercisable - March 31, 2014		2,480,042

The following table summarizes the restricted stock award in the ACO Plan during the nine months ended December 31, 2014:

	Shares	Weighted Average Remaining Vesting Life (Years)	Weighted Average Per Share Intrinsic Value		Weighted Average Per Share Fair Value
Balance, beginning of period	3,752,000	0.8	$	0.02	$	0.03
Granted	184,000	-		-		0.77
Released	(183,996)	-		-		-
Balance, end of period	3,752,004	0.1	$	0.70	$	0.07
Vested and exercisable, end of period	2,461,694

The following table summarizes the restricted stock award in the ACO Plan during the years ended January 31, 2014 and 2013:

	Shares		Weighted Average Remaining Life (Years)		Aggregate Intrinsic Value		Weighted Average Fair Value
Balance, February 1, 2012		-		-	$	-		-
Granted		3,690,000		1.9		36,900		0.01
Released
Balance, January 31, 2013		3,690,000		1.9		36,900		0.01
Granted		62,000		1.7		620		0.01
Released		-
Balance, January 31, 2014		3,752,000		1.0	$	37,520	$	0.01
Vested and exercisable - January 31, 2014		2,480,042

Total Unrecognized Compensation Costs Related To Non-Vested Stock-Based Compensation Arrangements

As of March 31, 2014, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under the Company’s 2010 and 2013 Equity Plans, and the ACO Plan’s and the weighted-average period of years expected to recognize those costs are as follows:

Common stock options	$	99,732
Restricted stock	$	201,380
ACO Plan restricted stock	$	10,525

As of December 31, 2014, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under the Company’s 2010 and 2013 Equity Plans, and the ACO Plan’s and the weighted-average period of years expected to recognize those costs are as follows:

Common stock options	$	193,376
Restricted stock	$	139,400
ACO Plan restricted stock	$	48,846

As of January 31, 2014, total unrecognized compensation costs related to non-vested common stock options granted under our 2010 and 2013 Equity Plans, and the ACO Plan and the weighted-average period of years expected to recognize those costs are as follows:

			Weighted
			Average
			Remaining
			Life
			(Years)
Common stock options	$	118,194		0.8
ACO Plan restricted stock	$	15,736		1.0

Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards

Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying condensed consolidated statement of operations as follows:

	Two months ended March 31,
	2014		2013
Stock-based compensation expense:
Cost of services	$	15,703	$	14,077
General and administrative		44,484		31,209
	$	60,187	$	45,286

Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying condensed consolidated statement of operations as follows:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2014		2013		2014		2013
Stock-based compensation expense:
Cost of services	$	1,227	$	54,134	$	12,148	$	629,643
General and administrative		155,325		(76,338)		1,120,062		1,469,165
	$	156,552	$	(22,204)	$	1,132,210	$	2,098,808

Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying consolidated statement of operations for the years ended January 31:

	2014		2013
Stock-based compensation expense:
Cost of services	$	616,902	$	550,710
General and administrative		1,540.955		1,511,018
	$	2,157,857	$	2,061,728

Warrants Outstanding

Warrants consisted of the following as of and for the two months ended March 31, 2014:

	Weighted Average Per Share
	Intrinsic		Number of
	Value		warrants
Outstanding at February 1, 2014	$	0.40		314,500
Granted		-		400,000
Exercised		-		-
Cancelled		-		-
Outstanding at March 31, 2014	$	0.20		714,500

				Weighted
				average				Weighted
Exercise Price Per		Warrants		remaining		Warrants		average
Share		outstanding		contractual life		exercisable		exercise price per share
$	1.1485		125,000		2.50		125,000	$	1.149
$	1.1485		25,000		2.50		25,000	$	1.149
$	4.5000		50,000		2.50		50,000	$	4.500
$	5.0000		10,000		3.74		10,000	$	5.000
$	4.5000		82,500		4.00		82,500	$	4.500
$	4.0000		22,000		4.00		22,000	$	4.000
$	10.0000		200,000		7.00		-	$	10.000
$	20.0000		200,000		7.00		-	$	20.000
			714,500		5.26		314,500		2.900

Warrants consisted of the following for the nine months ended December 31, 2014:

	Weighted Average Per Share
	Intrinsic		Number of
	Value		warrants
Outstanding, beginning of period	$	2.00	714,500
Granted		-	200,000
Exercised		-	-
Cancelled		-	-
Outstanding, end of period	$	-	914,500

			Weighted		Weighted
			average		average
Exercise Price Per		Warrants	remaining	Warrants	exercise price per
Share		outstanding	contractual life	exercisable	share
$	1.1485	125,000	1.6	125,000	$	1.149
$	1.1485	25,000	1.6	25,000	$	1.149
$	4.5000	50,000	1.6	50,000	$	4.500
$	5.0000	10,000	2.8	10,000	$	5.000
$	4.5000	82,500	3.1	82,500	$	4.500
$	4.0000	22,000	3.1	22,000	$	4.000
$	10.0000	200,000	6.2	-	$	10.000
$	20.0000	200,000	6.2	-	$	20.000
$	10.0000	100,000	6.2	-	$	10.000
$	10.0000	100,000	3.6	100,000	$	10.000
		914,500	4.5	414,500		4.600

Warrants consisted of the following:

	Aggregate
	Intrinsic		Number of
	Value		warrants
Outstanding at February 1, 2012	$	-		150,000
Granted		-		293,600
Exercised		-
Cancelled		-		(150,000)
Outstanding at January 31, 2013	$	-		293,600
Granted		-		20,900
Exercised		-		-
Cancelled		-		-
Outstanding at January 31, 2014	$	-		314,500

				Weighted
				average				Weighted
		Warrants		remaining		Warrants		average
Exercise Price		outstanding		contractual life		exercisable		exercise price
$	1.1485		125,000		2.50		125,000	$	1.149
$	1.1485		25,000		2.50		25,000	$	1.149
$	4.5000		50,000		2.50		50,000	$	4.500
$	5.0000		10,000		3.74		10,000	$	5.000
$	4.5000		82,500		4.00		82,500	$	4.500
$	4.0000		22,000		4.00		22,000	$	4.000
			314,500		3.04		314,500	$	2.882

Amount of Shares of Common Stock Reserved

The amount of shares of common stock reserved for these purposes is as follows at March 31, 2014:

Common stock issued and outstanding	4,913,455
Conversion of 9% Notes	275,000
Warrants outstanding	714,500
Stock options outstanding	628,700
Remaining shares issuable under 2013 Equity Incentive Plan	270,700
	6,802,355

The amount of shares of common stock reserved for these purposes is as follows at December 31, 2014: 

Common stock issued and outstanding	4,863,455
Conversion of 9% Notes	275,000
Conversion of 8% Notes	200,000
Warrants outstanding	914,500
Stock options outstanding	704,200
Remaining shares issuable under 2013 Equity Incentive Plan	160,000
	7,117,155

The amount of shares of common stock reserved for these purposes is as follows at January 31, 2014:

Common stock issued and outstanding	4,695,247
Conversion of 8% Notes (1)	18,208
Conversion of 9% Notes	275,000
Warrants outstanding	314,500
Stock options outstanding	735,800
Remaining shares issuable under 2013 Equity Incentive Plan	182,000
Shares and warrants issued in March 2014 (2)	600,000
	6,820,755

(1) Reflects shares issued in February 2014 in connection with the conversion of the 8% notes. See Note 10.

(2) Reflects 200,000 shares and 400,000 warrants issued in March 2014 in connection with an equity investment. See Note 10.